Aneurysmal Subarachnoid Hemorrhage Drugs Market Expected to Reach $206,675 Thousand : Latest Report on Analysis and In-depth Research on Market Size With top key Players Arbor Pharmaceuticals Inc., Edge Therapeutics, Inc., Johnson & Johnson (Actelion Phar

Aneurysmal subarachnoid hemorrhage is a kind of stroke, which is caused by bleeding in the subarachnoid space of the brain. The major reasons for aneurysmal subarachnoid hemorrhage include brain aneurysm, arteriovenous malformation, or head injury. Change in lifestyles such as smoking and alcohol consumption increase the risk for aSAH, as well as rise in geriatric population are the major factors that contribute to the growth of the market. Moreover, increase in prevalence of hypertension, and stroke further boost the market growth. However, the associated side effects of the drugs are expected to impede the market growth. In addition, a need to create awareness about the optimal diagnosis and treatment of aneurysmal subarachnoid hemorrhage provide lucrative opportunities for the market growth.

According to a new report published by Allied Market Research, titled, " Aneurysmal Subarachnoid Hemorrhage Drugs Market by Drug Class: Global Opportunity Analysis and Industry Forecast, 20172023," the global aneurysmal subarachnoid hemorrhage drugs market was valued at $160,269 thousand in 2016, and is estimated to reach $206,675 thousand by 2023, growing at a CAGR of 3.6% from 2017 to 2023.

Get sample copy of this report at:
www.alliedmarketresearch.com/request-sample/4602?utm_source=Prathm_OPR

Key Findings of the Aneurysmal Subarachnoid Hemorrhage Drugs Market:

• The opioid analgesics segment is expected to grow at a significant CAGR of 2.6% during the forecast period.

• The anticonvulsants segment contributed nearly one-fourth share of the global aneurysmal subarachnoid hemorrhage drugs market in 2016.

• The stool softeners segment is projected to grow at a significant CAGR of 4.2% during the forecast period.

• Germany and France are the major shareholders, which collectively accounted for more than one-third share of the European aneurysmal subarachnoid hemorrhage drugs market in 2016.

• Japan is the major shareholder, accounting for more than one-third share of the Asia-Pacific aneurysmal subarachnoid hemorrhage drugs market in 2016.

Opioid analgesics generated the maximum revenue, accounting for more than two-fifths share of the global aneurysmal subarachnoid hemorrhage drugs market in 2016. The calcium channel blockers segment is expected to witness the highest CAGR of 4.5% during the forecast period, owing to their ability to reduce the risk of brain damage

Get customized copy of this report at:
www.alliedmarketresearch.com/request-for-customization/4602?utm_source=Prathm_OPR

Key players in the market:

• Arbor Pharmaceuticals Inc.
• Edge Therapeutic Inc.
• Johnson & Johnson (Actelion Pharmaceuticals Ltd.)
• Mylan N.V.
• Orexo AB
• Pfizer Inc.
• Purdue Pharma L.P.
• Pharmaxis Ltd.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd. (Cephalon Inc.)

The Asia-Pacific market is projected to grow at the highest CAGR of 5.5% during the forecast period, owing to rise in awareness about the treatment of aneurysmal subarachnoid hemorrhage in the healthcare industry and surge in expenditures in emerging markets (such as India and China) to cater to the unmet medical needs.

LIST OF TABLES

TABLE 01. RISK FOR SUBARACHNOID HEMORRHAGE BASED ON SMOKING LEVEL
TABLE 02. PATIENTS TREATED, BY DRUG CLASS, 2015-2017
TABLE 03. GLOBAL ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 04. OPIOID ANALGESICS MARKET, BY REGION, 2016-2023 ($THOUSAND)
TABLE 05. CALCIUM CHANNEL BLOCKERS MARKET, BY REGION, 2016-2023 ($THOUSAND)
TABLE 06. ANTICONVULSANTS MARKET, BY REGION, 2016-2023 ($THOUSAND)
TABLE 07. STOOL SOFTENERS MARKET, BY REGION, 2016-2023 ($THOUSAND)
TABLE 08. OSMOTIC AGENTS/DIURETICS MARKET, BY REGION, 2016-2023 ($THOUSAND)
TABLE 09. OTHER DRUGS MARKET, BY REGION, 2016-2023 ($THOUSAND)
TABLE 10. ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY REGION, 2016-2023 ($THOUSAND)

LIST OF FIGURES

FIGURE 01. MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP PLAYER POSITIONING, 2016
FIGURE 04. IMPACT ANALYSES
FIGURE 05. COMPARATIVE ANALYSIS OF OPIOID ANALGESICS MARKET REVENUE, BY COUNTRY, 2016 & 2023(%)
FIGURE 06. COMPARATIVE ANALYSIS OF CALCIUM CHANNEL BLOCKERS MARKET REVENUE, BY COUNTRY, 2016 & 2023(%)
FIGURE 07. COMPARATIVE ANALYSIS OF ANTICONVULSANTS MARKET REVENUE, BY COUNTRY, 2016 & 2023(%)
FIGURE 08. COMPARATIVE ANALYSIS OF STOOL SOFTENERS MARKET REVENUE, BY COUNTRY, 2016 & 2023(%)
FIGURE 09. COMPARATIVE ANALYSIS OF OSMOTIC AGENTS/DIURETICS MARKET REVENUE, BY COUNTRY, 2016 & 2023(%)
FIGURE 10. COMPARATIVE ANALYSIS OF OTHER DRUGS MARKET REVENUE, BY COUNTRY, 2016 & 2023(%)
FIGURE 11. J&J: NET SALES, 2015-2017 ($MILLION)

Access full summary at:
https://www.alliedmarketresearch.com/aneurysmal-subarachnoid-hemorrhage-drugs-market?utm_source=Prathm_OPR

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.